Sunshine Biopharma Receives Health Canada Approval for Essential Calcium-Vitamin D(TM) Supplement

MONTREAL, QC / ACCESSWIRE / November 6, 2019 / Sunshine Biopharma, Inc. (OTCPINK:SBFM) today announced that it has received Health Canada approval for Essential Calcium-Vitamin D supplement, the second in a line of Essential Micronutrients Products that the Company is planning to launch. Health Canada issued NPN 80093432 through which it authorized Sunshine Biopharma to manufacture and sell a Calcium-Vitamin D supplement under the brand name Essential Calcium-Vitamin D. Essential Calcium-Vitamin D is a dietary supplement tablet that contains a balanced formula of Calcium and Vitamin D complex. Vitamin D plays a major role in multiple biological functions, including regulating the concentration of calcium and phosphate, and promoting the healthy growth and remodeling of bone. In addition, Vitamin D is involved in cell growth, neuromuscular and immune functions, and reduction of inflammation. Sunshine Biopharma anticipates that Essential Calcium-Vitamin D will be available on Amazon.ca in January 2020. The Company’s first Essential Micronutrients Product, Essential 9, launched earlier this year is currently available in Canada on Amazon.ca and in the US on Amazon.com.

About Essential Calcium Vitamin D

Vitamin D is a group of steroid-like molecules responsible for increasing intestinal absorption of calcium, magnesium, and phosphate. They are also involved in multiple other biological functions, including promoting the healthy growth and remodeling of bone, cell growth, neuromuscular and immune functions, and reduction of inflammation. The most important compounds in this group are Vitamin D2 (ergocalciferol) and Vitamin D3 (cholecalciferol). Sunshine Biopharma’s Essential Calcium-Vitamin D tablets contain both of these compounds as well as Calcium for optimum health benefits.

About Essential 9

Essential Amino Acids are 9 out of the 20 amino acids required for protein synthesis. Proteins are involved in all body functions – From the musculature and immune system to hormones and neurotransmitters. Like vitamins, Essential Amino Acids cannot be made by the human body and must be obtained through diet. Deficiency in one or more of the 9 Essential Amino Acids can lead to loss of muscle mass, fatigue, weight gain and reduced ability to build muscle mass in athletes. Sunshine Biopharma’s Essential 9 provides all 9 Essential Amino Acids in free-form and in the proportions recommended by Health Canada. Essential 9 is suitable for everyone: vegans, athletes, seniors, dieters. Essential 9 is currently available on Amazon.ca and Amazon.com.

Safe Harbor Forward-Looking Statements

To the extent that statements in this press release are not strictly historical, including statements as to revenue projections, business strategy, outlook, objectives, future milestones, plans, intentions, goals, future financial conditions, future collaboration agreements, the success of the Company’s development, events conditioned on stockholder or other approval, or otherwise as to future events, such statements are forward-looking, and are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. The forward-looking statements contained in this release are subject to certain risks and uncertainties that could cause actual results to differ materially from the statements made.

For Additional Information:

Sunshine Biopharma, Inc.
Camille Sebaaly, CFO
Direct Line: 514-814-0464
camille.sebaaly@sunshinebiopharma.com
www.sunshinebiopharma.com

SOURCE: Sunshine Biopharma Inc.

View source version on accesswire.com:
https://www.accesswire.com/565453/Sunshine-Biopharma-Receives-Health-Canada-Approval-for-Essential-Calcium-Vitamin-DTM-Supplement

Staff

Recent Posts

Grace Health Technology Launches New Laboratory Management Software

Live Sample Management Application Streamlines Laboratory Operations Software for Enhanced Laboratory Data Management Efficiency Secures…

2 hours ago

Avenues Recovery Center to Open at South Bend

Avenues Recovery is set to open a brand-new, 120-bed facility in Mishawaka, IndianaMISHAWAKA, IN /…

2 hours ago

Bristol Myers Squibb Expands Health Equity Grant Initiatives to Improve Health Outcomes

Company Awards $1.8M in Grants to Eight Organizations in Brazil, India, Thailand and the United…

5 hours ago

Universal Recall Platform Alliance Launches to Keep Patients Safe

Industry initiative URPA broadens calls to improve speed, accuracy of recall communicationWEST HOLLYWOOD, CA /…

5 hours ago

Elicio Therapeutics Reports 2023 Financial Results and Provides Corporate Updates

ELI-002 2P clinical immunogenicity data were accepted for a poster presentation at the AACR Annual…

8 hours ago

Molecular Templates, Inc. Reports Fourth Quarter 2023 Financial Results and Business Update

AUSTIN, Texas, March 29, 2024 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” or…

8 hours ago